Combination of Radiation Therapy, Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer
Cureus · 20.07.2024
DOI: 10.7759/cureus.64972 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 20.07.2024. Verfasst von Hisashi Nagai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Development - Environment and Resources, Graduate School of Human and Environmental Studies, Tokai University, Kanagawa, JPN. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Development - Environment and Resources, Graduate School of Human and Environmental Studies, Tokai University, Kanagawa, JPN.
- Department of Regenerative Medicine, Ginza Phoenix Clinic, Tokyo, JPN.
- Department of Respiratory Medicine, Yokohama City University Hospital, Yokohama, JPN.
- Laboratory of Molecular and Cellular Therapy, Institute for Advanced Medical Sciences, Hyogo Medical University, Hyogo, JPN.
Zitieren
APA
Nagai, H., Chen, H., Karube, R., Koitabashi, Y., Numata, O., & Yamahara, K. (2024). Combination of Radiation Therapy, Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer. Cureus. https://doi.org/10.7759/cureus.64972
Vancouver
Nagai H, Chen H, Karube R, Koitabashi Y, Numata O, Yamahara K. Combination of Radiation Therapy, Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer. Cureus. 2024. doi:10.7759/cureus.64972
BibTeX
@article{Nagai2024,
author = {Nagai, Hisashi and Chen, Hao and Karube, Ryusuke and Koitabashi, Yusuke and Numata, Ouka and Yamahara, Kenichi},
title = {Combination of Radiation Therapy, Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer},
journal = {Cureus},
year = {2024},
doi = {10.7759/cureus.64972}
}
EUVIMED